Clinical trial
Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T)…
NCT00235222 · Groupe Hospitalier Pitie-Salpetriere, Other · Unknown status
Key facts
| NCT number | NCT00235222 |
|---|---|
| Title | Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDY |
| Official title | Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDY |
| Lead sponsor | Groupe Hospitalier Pitie-Salpetriere, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV |
| Intervention type | Drug |
| Interventions | stavudine |
| Enrollment | 57 |
| Start date | Jun 1, 2004 |
| Completion | Mar 1, 2006 |
| First posted | Oct 10, 2005 |
| Last update posted | Oct 25, 2005 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: